Trial Profile
Combining Lifestyle Modification and Liraglutide to Improve Weight Loss and Health Outcomes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Acronyms MODEL
- 23 Nov 2019 Results assessing effects of Liraglutide and intensive behavioral therapy on food cravings, eating behaviors, and eating disorders, in patients with obesity, published in the Obesity (Silver Spring, Md.)
- 25 Feb 2019 Status changed from active, no longer recruiting to completed.
- 10 Sep 2018 Planned End Date changed from 1 Aug 2018 to 1 Dec 2018.